Literature DB >> 12851227

Serum ferritin and cardiovascular disease: a 17-year follow-up study in Busselton, Western Australia.

M W Knuiman1, M L Divitini, J K Olynyk, D J Cullen, H C Bartholomew.   

Abstract

The association between serum ferritin level and coronary heart disease (CHD) and stroke events was evaluated in a long-term Western Australia prospective study in 1981-1998. The cohort consisted of the 1612 men and women aged 40-89 years who participated in the 1981 Busselton Health Survey and who were free of cardiovascular disease at that time. Serum ferritin levels were obtained from serum samples stored frozen since 1981. The outcomes of interest were time to first CHD event (hospital admission or death) and time to first stroke event. Case-cohort sampling was used to reduce costs and preserve serum but still allow efficient analysis. Ferritin assays were performed for 217 CHD cases, 118 stroke cases, and a random sample of 450 of the total cohort. Proportional hazards regression models were used to obtain age-adjusted and multivariate-adjusted hazard ratios for ferritin level in relation to CHD and stroke. The hazard ratio for the highest tertile group compared with the lowest group was 0.96 (95% confidence interval: 0.60, 1.53) for CHD and 1.43 (95% confidence interval: 0.78, 2.64) for stroke. Little or no evidence was found that ferritin level was a risk factor for cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12851227     DOI: 10.1093/aje/kwg121

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  28 in total

1.  Serum ferritin-a novel risk factor in acute myocardial infarction.

Authors:  M P Holay; A A Choudhary; S D Suryawanshi
Journal:  Indian Heart J       Date:  2012-04-28

2.  Marginal hazards model for case-cohort studies with multiple disease outcomes.

Authors:  S Kang; J Cai
Journal:  Biometrika       Date:  2009-12       Impact factor: 2.445

Review 3.  Iron deficiency and cardiovascular disease: an updated review of the evidence.

Authors:  Emanuela Lapice; Maria Masulli; Olga Vaccaro
Journal:  Curr Atheroscler Rep       Date:  2013-10       Impact factor: 5.113

4.  Variable selection for case-cohort studies with failure time outcome.

Authors:  A I Ni; Jianwen Cai; Donglin Zeng
Journal:  Biometrika       Date:  2016-08-10       Impact factor: 2.445

5.  Ferritin couples iron and fatty acid metabolism.

Authors:  Weiming Bu; Renyu Liu; Jasmina C Cheung-Lau; Ivan J Dmochowski; Patrick J Loll; Roderic G Eckenhoff
Journal:  FASEB J       Date:  2012-02-23       Impact factor: 5.191

6.  More efficient estimators for case-cohort studies.

Authors:  S Kim; J Cai; W Lu
Journal:  Biometrika       Date:  2013       Impact factor: 2.445

7.  Serum ferritin is an independent factor in coronary artery stenosis among hemodialysis patients.

Authors:  Chen-Tung Lien; Chiang-Chin Tsai; Chien-An Chen; Chieh Kuo; Meng-Yi Tsai
Journal:  Int J Hematol       Date:  2016-06-21       Impact factor: 2.490

8.  Serum ferritin and obstructive sleep apnea-epidemiological study.

Authors:  Elin H Thorarinsdottir; Erna S Arnardottir; Bryndis Benediktsdottir; Christer Janson; Isleifur Olafsson; Allan I Pack; Thorarinn Gislason; Brendan T Keenan
Journal:  Sleep Breath       Date:  2017-12-09       Impact factor: 2.816

9.  Iron status is associated with carotid atherosclerotic plaques in middle-aged adults.

Authors:  Namanjeet Ahluwalia; Annelise Genoux; Jean Ferrieres; Bertrand Perret; Marion Carayol; Ludovic Drouet; Jean-Bernard Ruidavets
Journal:  J Nutr       Date:  2010-02-24       Impact factor: 4.798

10.  Iron stores, periodic leg movements, and sleepiness in obstructive sleep apnea.

Authors:  Louise M O'Brien; Julie Koo; Ludi Fan; Jocelynn T Owusu; Wattanachai Chotinaiwattarakul; Barbara T Felt; Ronald D Chervin
Journal:  J Clin Sleep Med       Date:  2009-12-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.